Ignite Creation Date:
2025-12-26 @ 5:24 PM
Ignite Modification Date:
2026-02-21 @ 11:29 PM
Study NCT ID:
NCT04166006
Status:
RECRUITING
Last Update Posted:
2024-09-19
First Post:
2019-11-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Study on Adjuvant Vaccination with Dendritic Cells Loaded with Autologous Tumor Homogenate in Resected Stage IV Rare Cancers.
Sponsor:
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-12-12
Start Date Type:
ACTUAL
Primary Completion Date:
2027-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2031-12
Completion Date Type:
ESTIMATED
First Submit Date:
2019-11-14
First Submit QC Date:
None
Study First Post Date:
2019-11-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-17
Last Update Post Date:
2024-09-19
Last Update Post Date Type:
ACTUAL